HomeANR • ASX
add
Anatara Lifesciences Ltd
Previous close
$0.057
Year range
$0.021 - $0.073
Market cap
11.84M AUD
Avg Volume
49.71K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
In the news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | -136.37K | 31.11% |
Operating expense | 46.19K | 121.17% |
Net income | -386.03K | 27.67% |
Net profit margin | 283.06 | 4.99% |
Earnings per share | — | — |
EBITDA | -387.78K | 27.95% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 982.11K | 144.80% |
Total assets | 1.67M | 17.76% |
Total liabilities | 306.85K | -37.99% |
Total equity | 1.36M | — |
Shares outstanding | 191.14M | — |
Price to book | 5.70 | — |
Return on assets | -58.05% | — |
Return on capital | -71.11% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -386.03K | 27.67% |
Cash from operations | -479.18K | 23.38% |
Cash from investing | 25.00K | 8,661.64% |
Cash from financing | 427.96K | 234.72% |
Net change in cash | -26.22K | 94.73% |
Free cash flow | -225.64K | 30.94% |
About
Founded
2010
Website
